Chinese genomics giant enters B.C. health research partnership
Five B.C. health-industry groups have agreed to form a research partnership with Chinese genomics giant BGI to advance medical technologies such as the treatment of cancer, officials said Wednesday.
The five groups — Providence Health Care, St. Paul’s Foundation, Vancouver Prostate Centre, Genome BC, and Deloitte — will work with BGI to apply genome-sequencing technology to patient therapy. No specific monetary figure for the partnership or details of the research projects were released.
The lack of specific numbers does not overshadow the potential magnitude of the agreement, said Pascal Spothelfer, president and CEO of Genome BC.
Chuck Chiang reports